Traphaco JSCSTC:TRA -0.13%83 Operating Margin % is 14.68% as of Mar. 2026, which is 3% above its 10-year median of 14.30. GuruFocus rates STC:TRA with a GF Score™ of 83/100 and a GF Value™ of ₫92,290.93 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 955 Drug Manufacturers companies, Traphaco JSC ranks better than 64.92% on this metric.
Operating Margin % is calculated as Operating Income divided by its Revenue. Traphaco JSC's Operating Income for the
three
months ended in Mar. 2026 was ₫92,897 Mil. Traphaco JSC's Revenue for the
three
months ended in Mar. 2026 was ₫632,847 Mil. Therefore, Traphaco JSC's Operating Margin % for the quarter that ended in Mar. 2026 was 14.68%.
Warning Sign:
Traphaco JSC operating margin has been in a 5-year decline. The average rate of decline per year is -3.3%.
The historical rank and industry rank for Traphaco JSC's Operating Margin % or its related term are showing as below:
STC:TRA'
s Operating Margin % Range Over the Past 10 Years
Min: 12.19 Med: 14.3 Max: 17.44
Current: 13.09
STC:TRA's Operating Margin % is ranked better than 64.92% of 955
companies
in the Drug Manufacturers industry
Industry Median: 7.45
vs STC:TRA: 13.09
Traphaco JSC's 5-Year Average Operating Margin % Growth Rate was -3.30% per year.
Traphaco JSC's Operating Income for the
three
months ended in Mar. 2026 was ₫92,897 Mil.
Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2026 was ₫361,751 Mil.
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
Traphaco JSC Operating Margin % Related Terms
Traphaco JSC Operating Margin % Historical Data
* Premium members only.
The historical data trend for Traphaco JSC's Operating Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Traphaco JSC's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Traphaco JSC Operating Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Traphaco JSC's Operating Margin % distribution charts can be found below:
* The bar in red indicates where Traphaco JSC's Operating Margin % falls into.
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
Traphaco JSC's Operating Margin % for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Traphaco JSC (STC:TRA) has a Operating Margin % of 14.68% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on Traphaco JSC and its competitors. This is near median its historical median of 14.30. Over the past decade, Traphaco JSC's Operating Margin % has ranged from 12.19 to 17.44. According to the industry distribution chart, Traphaco JSC ranks #335 out of 955 companies in the Drug Manufacturers industry, placing it in the top 35.1%.
Is Traphaco JSC's Operating Margin % too high?
Traphaco JSC's current Operating Margin % of 14.68% is near median its 10-year median of 14.30. Over the past 10 years, this metric has ranged from a low of 12.19 to a high of 17.44. The Drug Manufacturers industry median Operating Margin % is 7.45. Traphaco JSC's value of 14.68% is 97% above this industry median. Based on the distribution chart, Traphaco JSC ranks #335 out of 955 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Traphaco JSC has a GF Score™ of 83/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Traphaco JSC's Operating Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Traphaco JSC ranks #335 out of 955 companies for Operating Margin %. This puts Traphaco JSC in the upper half of its industry. The industry median Operating Margin % is 7.45. Traphaco JSC's value of 14.68% is 97% above this benchmark. Historically, Traphaco JSC's own Operating Margin % has ranged from 12.19 to 17.44 over the past decade. While the company's 10-year median is 14.30 vs. the industry median of 7.45, Traphaco JSC has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Drug Manufacturers company?
The median Operating Margin % among Drug Manufacturers companies is 7.45, based on 955 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Traphaco JSC's current Operating Margin % of 14.68% is 97% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Traphaco JSC and its competitors. For the Drug Manufacturers industry, the median Operating Margin % is 7.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Traphaco JSC's current Operating Margin % is 14.68%, which is near median its own 10-year median of 14.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Traphaco JSC stock overvalued right now?
Based on GuruFocus' analysis, Traphaco JSC (STC:TRA) is currently considered Modestly Undervalued. The stock's GF Value™ is ₫92,290.93, compared to a current price of ₫77,900.00 — trading 15.6% below its estimated fair value. The current Operating Margin % is 14.68%, which is near median its 10-year median of 14.30 and 97% above the Drug Manufacturers industry median of 7.45. Traphaco JSC's overall GF Score™ is 83/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Traphaco JSC (STC:TRA), the current Operating Margin % is 14.68% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Traphaco JSC (STC:TRA) Overvalued in 2026?
Based on GuruFocus' analysis, Traphaco JSC stock appears to be undervalued.
The current stock price of ₫77,900.00 is trading 15.6% below its estimated GF Value™ of ₫92,290.93.
GuruFocus considers Traphaco JSC to be Modestly Undervalued.
Key valuation signals for STC:TRA:
Operating Margin %: 14.68% (near median its 10-year median of 14.30)
GF Value™: ₫92,290.93 vs. price of ₫77,900.00 (15.6% below fair value)
Industry Position: 97% above the Drug Manufacturers median (#335 of 955)
No single metric tells the full story. See the STC:TRA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Traphaco JSC is engaged in the production and trading of pharmaceuticals, chemicals, and medical supplies and equipment. The company's products are used for nourishing the body, the Skeletal system, for hair, for eyes, the Nervous system, the Respiratory system, and Other groups.
83GF Score
Get the complete analysis for STC:TRA
Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STC:TRA has been successfully added to your 
